Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

HRT – Too great a risk ?

November 4, 2003 Research and Development HRT, clinical trial

The last 15 months have seen the image of HRT change from a miraculous medicine to a risky range of …
Feature

Smallpox vaccine puts Acambis into profit

November 3, 2003 Research and Development

News

Betaferon and Avonex in head-to-head MS trial

October 29, 2003 Research and Development, Sales and Marketing

Schering AG is to launch the largest ever therapeutic multiple sclerosis trial, comparing its drug Betaferon with Biogen's rival Avonex.The …
News

Aventis awards ClinPhone preferred supplier status

October 29, 2003 Research and Development

Aventis has made ClinPhone its preferred provider for data management of it clinical trials worldwide.Specialists in telephone and internet-based electronic …
News

New GSK joint venture malaria drug approved

October 29, 2003 Research and Development

News

New HRT study shows doubling of cancer risk

October 29, 2003 Research and Development

A new study of over one million UK women has confirmed an increased risk of breast cancer from all forms …
News

Merck expands into US proteomics

October 29, 2003 Research and Development

Merck KGaA has bought ProtoPlex, a US-based biotech company specialising in functional genomics and proteomics.Privately owned Protoplex will be integrated …
News

Genzyme buys SangStat for $600m

October 29, 2003 Research and Development

US biotech company Genzyme is to buy SangStat, a California-based company whose lead product Thymoglobulin is a $77 million-a-year treatment …
News

Troubled UK biotechs to merge

October 29, 2003 Research and Development

News

Pre-clinical marketing: understanding need

October 29, 2003 Research and Development marketing, pre-clinical

Since the modern pharmaceutical industry emerged, product development has been largely driven by science, with R&D seen almost exclusively as …
Feature

GSK pipeline fuelled by purchases

October 29, 2003 Research and Development

GlaxoSmithKline leads the industry in licensing in new drugs, buying the rights to nearly twice as many products as its …
News

Research body management draws criticism

October 29, 2003 Research and Development

News

CAT hopeful despite growing losses

October 28, 2003 Research and Development

News

Trial failure forces Xenova cutbacks

October 28, 2003 Research and Development

Xenova has halted phase III clinical trials of its lead product after an independent safety committee confirmed safety fears about …
News

Exanta shows positive results for AstraZeneca

October 28, 2003 Research and Development

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025